Humana Inc. reports news around its U.S. healthcare business, combining Humana insurance services with CenterWell healthcare services. Company updates commonly address Medicare Advantage and other health plan membership, Insurance segment benefit ratios, GAAP and adjusted earnings, full-year guidance, and capital returns through quarterly dividends.
News also covers CenterWell's senior-focused primary care, home health, pharmacy, hospice and retail pharmacy activities; prescription access and home delivery partnerships; healthcare research tied to medication adherence and chronic disease care; palliative care arrangements; health data interoperability; and board refreshment or other governance actions.
Humana Inc. (NYSE: HUM) will announce its financial results for the third quarter of 2022 on November 2, 2022, at 6:30 a.m. Eastern time. A conference call to discuss the results and earnings guidance for 2022 will follow at 9:00 a.m. Eastern time. Participants can join via telephone after registering through a provided link. The earnings report will likely include non-GAAP financial measures, reconciled to GAAP metrics. The earnings news release will be available on Humana’s Investor Relations page.
Humana Inc. (NYSE: HUM) has announced its 2023 Medicare Advantage and Prescription Drug Plan offerings, emphasizing member feedback. The initiative follows a commitment to $1 billion in cost savings for program enhancements. Humana offers more $0 premium plans, expanded coverage in 260 new counties, and enhanced benefits like dental care and simplified prescription access. The company aims to improve affordability and accessibility for Medicare beneficiaries.
Humana Inc. (NYSE: HUM) has committed $1 million to aid recovery efforts for Hurricane Ian in Florida and Hurricane Fiona in Puerto Rico. The funding will support immediate relief, focusing on basic needs like food, water, and medical care. Additionally, Humana established a crisis hotline offering free counseling services. To further support employees, the Humana Foundation will match employee donations up to $500. These actions showcase Humana's commitment to community support and health equity in the wake of these devastating storms.
Humana Inc. (NYSE: HUM) has received high rankings in the 2022 Hispanic Association on Corporate Responsibility (HACR) Corporate Inclusion Index. The company scored 5 out of 5 stars in Employment, Procurement, and Philanthropy, and 4 out of 5 stars in Governance. This recognition reflects Humana's commitment to supporting Hispanic and Latinx inclusion in various corporate spheres. The insights gained will guide Humana's strategic initiatives in diversity and belonging, aiming to foster an inclusive workplace culture.
Humana Inc. (NYSE: HUM) announced a mid-term Adjusted EPS target of $37.00 for FY 2025, indicating a 14% annual growth from the updated FY 2022 outlook. The company raised its FY 2022 GAAP EPS guidance to approximately $23.08 and Adjusted EPS to approximately $25.00, reflecting a 21% increase from FY 2021. This growth is attributed to favorable medical cost trends in Medicare Advantage and the absence of expected COVID-19 disruptions. Humana continues to emphasize operational efficiencies and capital deployment for sustained earnings growth.
Humana Inc. (NYSE: HUM) has elected Brad D. Smith, former Executive Chairman and CEO of Intuit, to its Board of Directors. Smith, currently the President of Marshall University, has a strong track record of transforming companies, including nearly doubling Intuit's revenue during his leadership. Humana's Chairman, Kurt J. Hilzinger, expressed confidence in Smith's ability to drive growth and operational efficiencies in Humana's Medicare Advantage business and enhance its healthcare services. With Smith's addition, Humana's Board now comprises 14 members.
Humana Inc. (NYSE: HUM) will host a virtual Investor Update on September 15, 2022, at 8:30 a.m. Eastern. The event will feature company leaders discussing Humana's strategic direction, operational and financial progress, and future performance expectations.
Participants can access the webcast through Humana’s Investor Relations page. For those unable to attend, a replay will be available approximately four hours after the event.
Humana aims to enhance health and lower costs through integrated care solutions for its members.
AM Best has affirmed Humana Inc.'s (NYSE: HUM) Financial Strength Rating (FSR) of A- (Excellent) and Long-Term Issuer Credit Ratings (ICR) of 'a-' (Excellent) for most of its health and dental insurance subsidiaries. The ratings reflect adequate balance sheet strength and operating performance, although recent challenges have outpaced net income. Humana remains the second-largest Medicare Advantage insurer in the U.S. and has expanded its Medicaid presence. The outlook for these ratings is stable, with financial leverage expected to decrease to approximately 40% by year-end 2022.
Humana Inc. has completed the rebranding of its home health division, Kindred at Home, to CenterWell Home Health, now operational in over 350 locations across 38 states. This initiative is integral to integrating home health services into Humana's broader business model, aiming to enhance patient outcomes.
With the rollout of the CenterWell brand, Humana focuses on unifying its healthcare services, including home health, primary care, and pharmacy, to provide a seamless care experience for its members, improving overall health and reducing costs.
Humana Inc. has partnered with Mays Business School at Texas A&M University to host the 2022 Humana-Mays Healthcare Analytics Case Competition. The competition, which aims to enhance students' analytical skills in addressing real-world healthcare challenges, offers a total prize package of $80,000 for winning teams. Eligible participants include graduate students from accredited U.S. institutions, competing in teams of 2 to 4. Key dates include registration opening on August 1, with finals announced on November 10.